To include your compound in the COVID-19 Resource Center, submit it here.

Rigel raises $60.6M in follow-on

Rigel Pharmaceuticals Inc. (NASDAQ:RIGL) raised $60.6 million on Oct. 4 through the sale of

Read the full 142 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE